| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VIPR1 CYSLTR2 ABCA1 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 CRIM1 MRGPRD GPR31 OPN3 ROR1 ROR2 NTSR2 OR2W1 GPR135 TAS2R38 PTGER2 F2RL2 PTGFR CHRNA2 CHRNA3 CHRNA5 CHRNB3 FFAR4 OPRD1 OPRL1 OR1D2 OR10D4P QRFPR TAS2R7 FCER1A OR11A1 P2RY2 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG CD79A TAS2R45 TAS2R31 TNFRSF1A TAS2R19 TAS2R46 GPR176 OR52B2 PTGDR2 HRH3 TMEM63A | 9.67e-26 | 1353 | 144 | 53 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VIPR1 CYSLTR2 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 TAS2R38 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 OR10D4P QRFPR TAS2R7 OR11A1 P2RY2 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG TAS2R45 TAS2R31 TAS2R19 TAS2R46 GPR176 OR52B2 PTGDR2 HRH3 | 2.72e-22 | 884 | 144 | 41 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA1 ABCA2 ABCA3 ATP7B SLC6A16 TRPC4 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 PKDREJ SLC29A2 ABCA10 CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 MFSD14A SLC6A13 PIEZO2 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 SLC16A6 SLC22A14 SLCO2A1 SLC22A1 KCNK2 SLC28A2 SLC7A5 ANO7 ZDHHC13 SLC14A2 ATP4A SLC4A9 MFSD10 TMEM63A | 1.49e-18 | 1180 | 144 | 42 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ABCA1 ABCA2 ABCA3 ATP7B SLC6A16 TRPC4 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 PKDREJ SLC29A2 ABCA10 CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 MFSD14A SLC6A13 PIEZO2 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 SLC16A6 SLC22A14 SLCO2A1 SLC22A1 KCNK2 SLC28A2 SLC7A5 ANO7 ZDHHC13 SLC14A2 ATP4A SLC4A9 MFSD10 TMEM63A | 3.63e-17 | 1289 | 144 | 42 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP7B TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 SLC6A13 PIEZO2 SLC8B1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 SLC28A2 ZDHHC13 ATP4A SLC4A9 TMEM63A | 1.11e-11 | 664 | 144 | 25 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP7B TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 SLC6A13 PIEZO2 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 SLC28A2 ANO7 ZDHHC13 ATP4A SLC4A9 TMEM63A | 1.50e-11 | 793 | 144 | 27 | GO:0015075 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA1 ABCA2 ABCA3 ATP7B SLC6A16 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 ABCA10 SLC6A3 SLC6A13 SLC8B1 SLC30A5 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 ATP4A SLC4A9 | 3.35e-11 | 477 | 144 | 21 | GO:0022804 |
| GeneOntologyMolecularFunction | taste receptor activity | TAS2R38 FFAR4 TAS2R7 TAS2R33 TAS2R45 TAS2R31 TAS2R19 TAS2R46 | 7.17e-11 | 33 | 144 | 8 | GO:0008527 |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 6.89e-10 | 27 | 144 | 7 | GO:0033038 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7B TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 SLC6A3 SLC6A13 SLC8B1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 SLC28A2 ZDHHC13 ATP4A SLC4A9 | 1.09e-09 | 465 | 144 | 19 | GO:0046873 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A16 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 SLC6A3 SLC6A13 SLC8B1 SLC30A5 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 SLC4A9 | 3.95e-09 | 296 | 144 | 15 | GO:0015291 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP7B TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 SLC6A3 SLC6A13 SLC8B1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 SLC28A2 ZDHHC13 ATP4A SLC4A9 TMEM63A | 2.57e-08 | 627 | 144 | 20 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP7B TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 SLC6A3 SLC6A13 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 SLC28A2 ANO7 ZDHHC13 ATP4A SLC4A9 TMEM63A | 2.60e-08 | 758 | 144 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 3.37e-07 | 21 | 144 | 5 | GO:0005326 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.23e-07 | 133 | 144 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 5.51e-07 | 23 | 144 | 5 | GO:0015464 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 6.20e-07 | 43 | 144 | 6 | GO:0140828 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 8.07e-07 | 140 | 144 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7B SLC30A8 SLC38A5 SLC30A2 SLC6A3 SLC6A13 SLC8B1 SLC30A5 SLC22A1 SLC28A2 ATP4A SLC4A9 | 1.95e-06 | 301 | 144 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | zinc:proton antiporter activity | 3.63e-06 | 5 | 144 | 3 | GO:0140826 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 4.41e-06 | 16 | 144 | 4 | GO:0004953 | |
| GeneOntologyMolecularFunction | gated channel activity | CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 PIEZO2 CLCN1 KCNA5 KCNQ5 KCNK2 ANO7 TMEM63A | 5.67e-06 | 334 | 144 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 5.74e-06 | 17 | 144 | 4 | GO:0022848 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPC4 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 PIEZO2 CLCN1 KCNA5 KCNQ5 KCNK2 ANO7 TMEM63A | 6.11e-06 | 459 | 144 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | antiporter activity | 7.25e-06 | 138 | 144 | 8 | GO:0015297 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPC4 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 PIEZO2 KCNA5 KCNQ5 KCNK2 TMEM63A | 7.42e-06 | 343 | 144 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLCO4A1 SLC38A5 SLC7A6 SLC6A13 SLC16A6 SLC22A14 SLCO2A1 SLC22A1 SLC7A5 SLC4A9 MFSD10 | 9.35e-06 | 293 | 144 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 2.00e-05 | 8 | 144 | 3 | GO:0015214 | |
| GeneOntologyMolecularFunction | channel activity | TRPC4 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 PIEZO2 CLCN1 KCNA5 KCNQ5 KCNK2 ANO7 TMEM63A | 2.74e-05 | 525 | 144 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPC4 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 PIEZO2 CLCN1 KCNA5 KCNQ5 KCNK2 ANO7 TMEM63A | 2.80e-05 | 526 | 144 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.44e-05 | 171 | 144 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 4.00e-05 | 27 | 144 | 4 | GO:0051139 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 4.25e-05 | 10 | 144 | 3 | GO:0005337 | |
| GeneOntologyMolecularFunction | prostaglandin F receptor activity | 5.16e-05 | 2 | 144 | 2 | GO:0004958 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 5.81e-05 | 11 | 144 | 3 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 7.70e-05 | 12 | 144 | 3 | GO:0004954 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 9.00e-05 | 196 | 144 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 9.96e-05 | 13 | 144 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 1.26e-04 | 14 | 144 | 3 | GO:1901474 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.26e-04 | 14 | 144 | 3 | GO:0015132 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.39e-04 | 109 | 144 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.42e-04 | 37 | 144 | 4 | GO:0042923 | |
| GeneOntologyMolecularFunction | ethanolaminephosphotransferase activity | 1.54e-04 | 3 | 144 | 2 | GO:0004307 | |
| GeneOntologyMolecularFunction | norepinephrine:sodium symporter activity | 1.54e-04 | 3 | 144 | 2 | GO:0005334 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.57e-04 | 15 | 144 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.09e-04 | 75 | 144 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 2.32e-04 | 17 | 144 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.57e-04 | 43 | 144 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.77e-04 | 18 | 144 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 2.81e-04 | 44 | 144 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.94e-04 | 125 | 144 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.00e-04 | 81 | 144 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | purine nucleoside transmembrane transporter activity | 3.07e-04 | 4 | 144 | 2 | GO:0015211 | |
| GeneOntologyMolecularFunction | dopamine:sodium symporter activity | 3.07e-04 | 4 | 144 | 2 | GO:0005330 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 3.07e-04 | 4 | 144 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 3.27e-04 | 19 | 144 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.36e-04 | 83 | 144 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.27e-04 | 49 | 144 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.98e-04 | 51 | 144 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 5.09e-04 | 5 | 144 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 5.12e-04 | 22 | 144 | 3 | GO:0016780 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 5.85e-04 | 23 | 144 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 6.65e-04 | 24 | 144 | 3 | GO:0005385 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 7.60e-04 | 6 | 144 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 7.62e-04 | 57 | 144 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | symporter activity | 7.74e-04 | 150 | 144 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 7.91e-04 | 100 | 144 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.01e-04 | 151 | 144 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase kinase binding | 8.46e-04 | 26 | 144 | 3 | GO:0031435 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 8.46e-04 | 26 | 144 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 9.25e-04 | 60 | 144 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 9.46e-04 | 27 | 144 | 3 | GO:0015271 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.05e-03 | 28 | 144 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 1.06e-03 | 7 | 144 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.06e-03 | 7 | 144 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR7E24 OR2W1 OR1D2 OR10D4P OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 1.16e-03 | 431 | 144 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.25e-03 | 65 | 144 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.25e-03 | 65 | 144 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | CDP-alcohol phosphatidyltransferase activity | 1.41e-03 | 8 | 144 | 2 | GO:0017169 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.52e-03 | 171 | 144 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.72e-03 | 119 | 144 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 1.80e-03 | 9 | 144 | 2 | GO:0015349 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.86e-03 | 178 | 144 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 2.24e-03 | 10 | 144 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.34e-03 | 77 | 144 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 2.72e-03 | 11 | 144 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 2.72e-03 | 11 | 144 | 2 | GO:0019870 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.72e-03 | 11 | 144 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.79e-03 | 193 | 144 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.09e-03 | 197 | 144 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 3.25e-03 | 12 | 144 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | arrestin family protein binding | 3.25e-03 | 12 | 144 | 2 | GO:1990763 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.48e-03 | 140 | 144 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 3.82e-03 | 13 | 144 | 2 | GO:0015173 | |
| GeneOntologyMolecularFunction | icosanoid binding | 5.80e-03 | 16 | 144 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 5.80e-03 | 16 | 144 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 5.80e-03 | 16 | 144 | 2 | GO:0045125 | |
| GeneOntologyMolecularFunction | floppase activity | 5.80e-03 | 16 | 144 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 6.39e-03 | 102 | 144 | 4 | GO:0005249 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 6.61e-03 | 53 | 144 | 3 | GO:0008188 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | VIPR1 CYSLTR2 ABCA1 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 CAV2 TAS2R38 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 OR10D4P QRFPR TAS2R7 OR11A1 P2RY2 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG KCNK2 TAS2R45 TAS2R31 TAS2R19 TAS2R46 GPR176 OR52B2 PTGDR2 HRH3 | 7.00e-18 | 1395 | 145 | 44 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR7E24 OR2W1 TAS2R38 KCNK4 CHRNA5 FFAR4 OR1D2 OR10D4P TAS2R7 PIEZO2 OR11A1 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 OR52B2 | 8.11e-10 | 582 | 145 | 21 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR7E24 OPN3 OR2W1 TAS2R38 PKDREJ KCNK4 CHRNA5 FFAR4 OR1D2 OR10D4P TAS2R7 PIEZO2 OR11A1 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 OR52B2 | 1.31e-09 | 722 | 145 | 23 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | TAS2R38 FFAR4 TAS2R7 TAS2R33 TAS2R45 TAS2R31 TAS2R19 TAS2R46 | 2.05e-09 | 50 | 145 | 8 | GO:0050912 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR7E24 OR2W1 TAS2R38 FFAR4 OR1D2 OR10D4P TAS2R7 OR11A1 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 OR52B2 | 9.41e-09 | 485 | 145 | 18 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR7E24 OR2W1 TAS2R38 FFAR4 OR1D2 OR10D4P SLC6A3 TAS2R7 OR11A1 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 OR52B2 | 1.03e-08 | 547 | 145 | 19 | GO:0007606 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 SLC6A13 PIEZO2 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 ANO7 ZDHHC13 ATP4A SLC4A9 TMEM63A | 1.52e-08 | 1115 | 145 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLCO4A1 SLC38A5 SLC30A2 PKDREJ CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 OPRD1 SLC6A3 SLC6A13 PIEZO2 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 ANO7 ZDHHC13 ATP4A SLC4A9 HRH3 TMEM63A | 2.20e-08 | 1374 | 145 | 30 | GO:0006811 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 2.26e-08 | 44 | 145 | 7 | GO:0001580 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR7E24 OR2W1 TAS2R38 FFAR4 OR1D2 OR10D4P TAS2R7 OR11A1 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 OR52B2 | 3.08e-08 | 524 | 145 | 18 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of taste | TAS2R38 FFAR4 TAS2R7 TAS2R33 TAS2R45 TAS2R31 TAS2R19 TAS2R46 | 3.21e-08 | 70 | 145 | 8 | GO:0050909 |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 4.24e-08 | 48 | 145 | 7 | GO:0050913 | |
| GeneOntologyBiologicalProcess | sensory perception | OR7E24 ROR1 NTSR2 OR2W1 TAS2R38 KCNK4 CHRNA5 FFAR4 OPRL1 OR1D2 OR10D4P SLC6A3 TAS2R7 PIEZO2 OR11A1 TAS2R33 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 OR52B2 | 1.16e-07 | 1072 | 145 | 25 | GO:0007600 |
| GeneOntologyBiologicalProcess | organic anion transport | NPY5R TRPC4 SLCO4A1 SLC38A5 SLC7A6 SLC6A13 SLC16A6 P2RY2 SLC22A14 SLCO2A1 SLC22A1 SLC7A5 PRAF2 SLC4A9 MFSD10 HRH3 | 7.23e-07 | 515 | 145 | 16 | GO:0015711 |
| GeneOntologyBiologicalProcess | amino acid transport | NPY5R SLC6A16 TRPC4 SLC38A5 SLC7A6 SLC6A3 SLC6A13 SLC7A5 PRAF2 HRH3 | 1.24e-06 | 195 | 145 | 10 | GO:0006865 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 2.68e-06 | 87 | 145 | 7 | GO:0150104 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 SLC6A3 SLC6A13 PIEZO2 SLC8B1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 ZDHHC13 ATP4A SLC4A9 TMEM63A | 2.75e-06 | 942 | 145 | 21 | GO:0098655 |
| GeneOntologyBiologicalProcess | vascular transport | 2.90e-06 | 88 | 145 | 7 | GO:0010232 | |
| GeneOntologyBiologicalProcess | response to nicotine | 3.26e-06 | 58 | 145 | 6 | GO:0035094 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 5.83e-06 | 64 | 145 | 6 | GO:0042908 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | VIPR1 ABCA1 OXER1 PTGER2 PTGFR FFAR4 OPRD1 OPRL1 GPR176 PTGDR2 HRH3 | 5.88e-06 | 286 | 145 | 11 | GO:0007188 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | NPY5R TRPC4 SLCO4A1 SLC38A5 SLC7A6 SLC6A13 SLC16A6 P2RY2 SLCO2A1 SLC22A1 SLC7A5 PRAF2 HRH3 | 6.75e-06 | 410 | 145 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | NPY5R TRPC4 SLCO4A1 SLC38A5 SLC7A6 SLC6A13 SLC16A6 P2RY2 SLCO2A1 SLC22A1 SLC7A5 PRAF2 HRH3 | 7.11e-06 | 412 | 145 | 13 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 OPRD1 SLC6A3 SLC6A13 PIEZO2 SLC8B1 SLC30A5 KCNA5 KCNQ5 SLC22A1 KCNK2 ZDHHC13 ATP4A SLC4A9 TMEM63A | 1.94e-05 | 1157 | 145 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 2.78e-05 | 124 | 145 | 7 | GO:0007218 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 2.90e-05 | 51 | 145 | 5 | GO:0095500 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 SLC6A3 SLC6A13 SLC8B1 CLCN1 SLC30A5 KCNA5 KCNQ5 KCNK2 ANO7 ZDHHC13 ATP4A SLC4A9 | 3.01e-05 | 1017 | 145 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 3.22e-05 | 86 | 145 | 6 | GO:0007193 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 3.50e-05 | 53 | 145 | 5 | GO:1905145 | |
| GeneOntologyBiologicalProcess | positive regulation of secondary metabolite biosynthetic process | 3.94e-05 | 10 | 145 | 3 | GO:1900378 | |
| GeneOntologyBiologicalProcess | positive regulation of melanin biosynthetic process | 3.94e-05 | 10 | 145 | 3 | GO:0048023 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 4.36e-05 | 133 | 145 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 4.44e-05 | 91 | 145 | 6 | GO:0140115 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 4.59e-05 | 56 | 145 | 5 | GO:1905144 | |
| GeneOntologyBiologicalProcess | zinc ion import into organelle | 5.39e-05 | 11 | 145 | 3 | GO:0062111 | |
| GeneOntologyBiologicalProcess | organic cation transport | 7.55e-05 | 145 | 145 | 7 | GO:0015695 | |
| GeneOntologyBiologicalProcess | metal ion transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 OPRD1 SLC6A3 SLC6A13 SLC8B1 SLC30A5 KCNA5 KCNQ5 KCNK2 ZDHHC13 ATP4A SLC4A9 | 7.65e-05 | 1000 | 145 | 19 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP7B SLC6A16 TRPC4 SLC30A8 SLC38A5 SLC30A2 PKDREJ KCNK4 SLC6A3 SLC6A13 SLC8B1 SLC30A5 KCNA5 KCNQ5 KCNK2 ZDHHC13 ATP4A SLC4A9 | 8.52e-05 | 922 | 145 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | prostaglandin transport | 9.22e-05 | 34 | 145 | 4 | GO:0015732 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | SLC6A16 SLC29A2 CHRNA3 SLC6A3 SLC6A13 P2RY2 SLC22A1 SLC28A2 HRH3 | 9.28e-05 | 259 | 145 | 9 | GO:0006836 |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 1.25e-04 | 69 | 145 | 5 | GO:0098926 | |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 1.46e-04 | 15 | 145 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | azole transmembrane transport | 1.46e-04 | 15 | 145 | 3 | GO:0045117 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 1.64e-04 | 73 | 145 | 5 | GO:0071715 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | TRPC4 NTSR2 CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 OPRD1 PIEZO2 SLC8B1 CLCN1 KCNA5 KCNK2 | 1.64e-04 | 559 | 145 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of secondary metabolite biosynthetic process | 1.78e-04 | 16 | 145 | 3 | GO:1900376 | |
| GeneOntologyBiologicalProcess | regulation of melanin biosynthetic process | 1.78e-04 | 16 | 145 | 3 | GO:0048021 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound transmembrane transport | 1.78e-04 | 16 | 145 | 3 | GO:0072531 | |
| GeneOntologyBiologicalProcess | regulation of secondary metabolic process | 1.78e-04 | 16 | 145 | 3 | GO:0043455 | |
| GeneOntologyBiologicalProcess | lipid transport | ABCA1 ABCA2 ABCA3 SREBF2 SLCO4A1 ABCA10 P2RY2 SLCO2A1 SLC22A1 DISP3 ANO7 HRH3 | 2.46e-04 | 506 | 145 | 12 | GO:0006869 |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 2.56e-04 | 44 | 145 | 4 | GO:0006882 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 2.56e-04 | 44 | 145 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 2.78e-04 | 179 | 145 | 7 | GO:0032368 | |
| GeneOntologyBiologicalProcess | inosine transport | 2.92e-04 | 4 | 145 | 2 | GO:0035340 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 3.04e-04 | 19 | 145 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR7E24 OR2W1 OR1D2 OR10D4P SLC6A3 OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 4.58e-04 | 465 | 145 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | adenosine transport | 4.84e-04 | 5 | 145 | 2 | GO:0032238 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 4.84e-04 | 5 | 145 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | purine nucleoside transmembrane transport | 4.84e-04 | 5 | 145 | 2 | GO:0015860 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 4.88e-04 | 52 | 145 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 5.08e-04 | 142 | 145 | 6 | GO:0018958 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | DPAGT1 ABCA1 ABCA2 OPN3 CYP26A1 SREBF2 SLCO4A1 DUOX2 SLC6A3 TYRP1 ASIP DISP3 ALG6 | 6.06e-04 | 641 | 145 | 13 | GO:1901615 |
| GeneOntologyBiologicalProcess | eating behavior | 6.48e-04 | 56 | 145 | 4 | GO:0042755 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol efflux | 6.48e-04 | 56 | 145 | 4 | GO:0010874 | |
| GeneOntologyBiologicalProcess | lipid localization | ABCA1 ABCA2 ABCA3 SREBF2 SLCO4A1 ABCA10 P2RY2 SLCO2A1 SLC22A1 DISP3 ANO7 HRH3 | 6.60e-04 | 565 | 145 | 12 | GO:0010876 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.84e-04 | 208 | 145 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | phenol-containing compound biosynthetic process | 6.93e-04 | 57 | 145 | 4 | GO:0046189 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside transport | 7.23e-04 | 6 | 145 | 2 | GO:0015864 | |
| GeneOntologyBiologicalProcess | uridine transmembrane transport | 7.23e-04 | 6 | 145 | 2 | GO:0015862 | |
| GeneOntologyBiologicalProcess | protein lipidation | 7.39e-04 | 101 | 145 | 5 | GO:0006497 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCA2 SLC38A5 SLC29A2 SLC6A13 KCNA5 P2RY2 SLC22A1 SLC28A2 SLC7A5 | 7.48e-04 | 344 | 145 | 9 | GO:0003018 |
| GeneOntologyBiologicalProcess | melanin biosynthetic process | 7.86e-04 | 26 | 145 | 3 | GO:0042438 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 7.87e-04 | 213 | 145 | 7 | GO:0015718 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 8.31e-04 | 215 | 145 | 7 | GO:1905952 | |
| GeneOntologyBiologicalProcess | lipid translocation | 8.42e-04 | 60 | 145 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 9.19e-04 | 106 | 145 | 5 | GO:0042158 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR7E24 OR2W1 OR1D2 OR10D4P OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 9.79e-04 | 432 | 145 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | secondary metabolite biosynthetic process | 9.80e-04 | 28 | 145 | 3 | GO:0044550 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid transport | 9.80e-04 | 28 | 145 | 3 | GO:0015812 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 9.90e-04 | 358 | 145 | 9 | GO:0015850 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transport | 1.01e-03 | 7 | 145 | 2 | GO:0015855 | |
| GeneOntologyBiologicalProcess | zinc ion transmembrane transport | 1.09e-03 | 29 | 145 | 3 | GO:0071577 | |
| GeneOntologyBiologicalProcess | melanin metabolic process | 1.09e-03 | 29 | 145 | 3 | GO:0006582 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.14e-03 | 65 | 145 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.14e-03 | 65 | 145 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.18e-03 | 167 | 145 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | zinc ion transport | 1.20e-03 | 30 | 145 | 3 | GO:0006829 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | ABCA1 ABCA2 ABCA3 RASA1 CYP26A1 EI24 CHRNA3 SLC6A3 SLC22A1 SLC28A2 ATP4A | 1.23e-03 | 525 | 145 | 11 | GO:0009410 |
| GeneOntologyBiologicalProcess | export from cell | ABCA1 ABCA3 NPY5R ATP7B EQTN SLC30A8 SLC38A5 SLC30A2 F2RL2 CHRNA3 FFAR4 SLC8B1 FCER1A KCNA5 P2RY2 TNFRSF1A ATP4A HRH3 | 1.24e-03 | 1153 | 145 | 18 | GO:0140352 |
| GeneOntologyBiologicalProcess | nucleoside transmembrane transport | 1.34e-03 | 8 | 145 | 2 | GO:1901642 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 1.34e-03 | 8 | 145 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 1.34e-03 | 8 | 145 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | purine nucleobase transmembrane transport | 1.34e-03 | 8 | 145 | 2 | GO:1904823 | |
| GeneOntologyBiologicalProcess | serotonin transport | 1.45e-03 | 32 | 145 | 3 | GO:0006837 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 1.57e-03 | 240 | 145 | 7 | GO:0070374 | |
| GeneOntologyBiologicalProcess | fusion of sperm to egg plasma membrane involved in single fertilization | 1.59e-03 | 33 | 145 | 3 | GO:0007342 | |
| GeneOntologyBiologicalProcess | GPI anchor biosynthetic process | 1.59e-03 | 33 | 145 | 3 | GO:0006506 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.60e-03 | 120 | 145 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 1.64e-03 | 385 | 145 | 9 | GO:0070372 | |
| GeneOntologyBiologicalProcess | norepinephrine uptake | 1.71e-03 | 9 | 145 | 2 | GO:0051620 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCA1 ATP7B TRPC4 SLCO4A1 SLC29A2 SLC6A13 SLC16A6 P2RY2 PROM2 SLCO2A1 SLC22A1 SLC7A5 SLC14A2 SLC4A9 | 5.74e-08 | 320 | 146 | 14 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | ABCA1 ATP7B TRPC4 SLCO4A1 SLC29A2 SLC6A13 SLC16A6 P2RY2 PROM2 SLCO2A1 SLC22A1 SLC7A5 SLC14A2 SLC4A9 | 1.98e-07 | 354 | 146 | 14 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | ABCA1 ATP7B TRPC4 SLCO4A1 SLC29A2 SLC6A13 SLC16A6 P2RY2 PROM2 SLCO2A1 SLC22A1 SLC7A5 SLC14A2 SLC4A9 | 4.38e-07 | 378 | 146 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 6.48e-06 | 18 | 146 | 4 | GO:0005892 | |
| GeneOntologyCellularComponent | membrane raft | ABCA1 SPAM1 TRPC4 CAV2 CHRNA3 SLC6A3 MFAP3 FCER1A KCNA5 PROM2 CD79A TNFRSF1A | 9.33e-06 | 362 | 146 | 12 | GO:0045121 |
| GeneOntologyCellularComponent | cell surface | ABCA1 SPAM1 TRPC4 ROR1 ROR2 ITGA10 NTSR2 DUOX2 CAV2 CD163 SLC6A3 CLEC4E MFAP3 FCER1A KCNA5 PROM2 KCNK2 SLC7A5 CD79A ADAM2 ALCAM TNFRSF1A | 9.40e-06 | 1111 | 146 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | membrane microdomain | ABCA1 SPAM1 TRPC4 CAV2 CHRNA3 SLC6A3 MFAP3 FCER1A KCNA5 PROM2 CD79A TNFRSF1A | 9.86e-06 | 364 | 146 | 12 | GO:0098857 |
| GeneOntologyCellularComponent | dopaminergic synapse | 1.51e-05 | 22 | 146 | 4 | GO:0098691 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | ABCA2 CATSPERE TRPC4 COX6A2 CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 CLCN1 KCNA5 KCNQ5 KCNK2 ATP4A | 1.86e-05 | 523 | 146 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | ABCA2 CATSPERE TRPC4 COX6A2 CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 CLCN1 KCNA5 KCNQ5 KCNK2 ATP4A | 3.24e-05 | 550 | 146 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | plasma membrane protein complex | ABCA2 CATSPERE ITGA10 DUOX2 CAV2 CHRNA2 CHRNA3 CHRNA5 CHRNB3 SLC6A3 KCNA5 KCNQ5 KCNK2 SLC7A5 CD79A ALCAM ATP4A | 3.54e-05 | 785 | 146 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | vesicle membrane | ABCA2 ABCA3 DNAJC13 ROR2 EQTN SLC30A8 SREBF2 GPR135 CAV2 SLC30A2 CD163 FFAR4 OPRD1 TBC1D10C TYRP1 CLEC4E SLC30A5 SLC28A2 DISP3 PRAF2 ZDHHC13 MFSD10 TMEM63A | 4.66e-05 | 1325 | 146 | 23 | GO:0012506 |
| GeneOntologyCellularComponent | apical part of cell | ATP7B DUOX2 F2RL2 SLC29A2 SLC30A5 KCNA5 P2RY2 PROM2 SLC22A1 KCNK2 SLC7A5 SLC14A2 ATP4A SLC4A9 | 7.15e-05 | 592 | 146 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CATSPERE TRPC4 CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 CLCN1 KCNA5 KCNQ5 KCNK2 | 7.24e-05 | 378 | 146 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCA2 ABCA3 DNAJC13 ROR2 EQTN SLC30A8 SREBF2 GPR135 CAV2 SLC30A2 CD163 FFAR4 OPRD1 TBC1D10C TYRP1 CLEC4E SLC30A5 DISP3 PRAF2 ZDHHC13 MFSD10 TMEM63A | 1.09e-04 | 1307 | 146 | 22 | GO:0030659 |
| GeneOntologyCellularComponent | membrane protein complex | ABCA2 CATSPERE TRPC4 COX6A2 SREBF2 ITGA10 DUOX2 CAV2 PIGU CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 CLCN1 KCNA5 KCNQ5 KCNK2 SLC7A5 CD79A ALCAM RNF139 ATP4A | 1.10e-04 | 1498 | 146 | 24 | GO:0098796 |
| GeneOntologyCellularComponent | apical plasma membrane | DUOX2 F2RL2 SLC29A2 SLC30A5 KCNA5 P2RY2 PROM2 SLC22A1 KCNK2 SLC7A5 SLC14A2 ATP4A | 1.64e-04 | 487 | 146 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | secretory granule membrane | ABCA3 DNAJC13 EQTN SLC30A8 CAV2 SLC30A2 TBC1D10C SLC30A5 TMEM63A | 5.20e-04 | 329 | 146 | 9 | GO:0030667 |
| GeneOntologyCellularComponent | receptor complex | VIPR1 ROR1 ROR2 ITGA10 CHRNA2 CHRNA3 CHRNA5 CHRNB3 CD79A ALCAM TNFRSF1A | 2.60e-03 | 581 | 146 | 11 | GO:0043235 |
| MousePheno | decreased physiological sensitivity to xenobiotic | DAB2IP PTGER2 CHRNA2 FFAR4 OPRD1 SLC6A3 CLEC4E CLCN1 KCNA5 KCNK2 TNFRSF1A HRH3 | 1.37e-06 | 283 | 105 | 12 | MP:0008874 |
| MousePheno | abnormal prostaglandin level | 3.96e-05 | 26 | 105 | 4 | MP:0009811 | |
| Domain | GPCR_Rhodpsn_7TM | CYSLTR2 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 QRFPR TAS2R7 OR11A1 P2RY2 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG GPR176 OR52B2 PTGDR2 HRH3 | 4.03e-18 | 670 | 141 | 33 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | CYSLTR2 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 QRFPR TAS2R7 OR11A1 P2RY2 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG GPR176 OR52B2 PTGDR2 HRH3 | 1.01e-17 | 691 | 141 | 33 | PS50262 |
| Domain | GPCR_Rhodpsn | CYSLTR2 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 QRFPR TAS2R7 OR11A1 P2RY2 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG GPR176 OR52B2 PTGDR2 HRH3 | 1.06e-17 | 692 | 141 | 33 | IPR000276 |
| Domain | 7tm_1 | CYSLTR2 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 QRFPR OR11A1 P2RY2 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG GPR176 OR52B2 PTGDR2 HRH3 | 4.65e-17 | 677 | 141 | 32 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | CYSLTR2 OXER1 GPR15 OR7E24 NPY5R MAS1L LPAR4 MRGPRD GPR31 OPN3 NTSR2 OR2W1 GPR135 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 OR1D2 QRFPR OR11A1 P2RY2 OR6C70 OR52H1 OR6C75 OR10W1 MRGPRG GPR176 OR52B2 PTGDR2 HRH3 | 6.51e-17 | 685 | 141 | 32 | PS00237 |
| Domain | TAS2R | 3.38e-08 | 26 | 141 | 6 | PF05296 | |
| Domain | T2R | 3.38e-08 | 26 | 141 | 6 | IPR007960 | |
| Domain | ABC_A | 1.47e-06 | 12 | 141 | 4 | IPR026082 | |
| Domain | Nicotinic_acetylcholine_rcpt | 5.28e-06 | 16 | 141 | 4 | IPR002394 | |
| Domain | MFS_dom | SLCO4A1 SLC29A2 MFSD14A SLC16A6 SLC22A14 SLCO2A1 SLC22A1 MFSD10 | 8.09e-06 | 134 | 141 | 8 | IPR020846 |
| Domain | MFS | 1.78e-05 | 108 | 141 | 7 | PS50850 | |
| Domain | - | 2.47e-05 | 23 | 141 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.47e-05 | 23 | 141 | 4 | IPR027361 | |
| Domain | Cation_efflux | 4.86e-05 | 10 | 141 | 3 | IPR002524 | |
| Domain | Cation_efflux | 4.86e-05 | 10 | 141 | 3 | PF01545 | |
| Domain | Tyr_kinase_rcpt_ROR | 5.66e-05 | 2 | 141 | 2 | IPR016247 | |
| Domain | - | 6.65e-05 | 11 | 141 | 3 | 1.20.1510.10 | |
| Domain | Cation_efflux_TMD | 6.65e-05 | 11 | 141 | 3 | IPR027469 | |
| Domain | MRGPCRFAMILY | 6.65e-05 | 11 | 141 | 3 | IPR026234 | |
| Domain | ABC_transporter_CS | 2.79e-04 | 42 | 141 | 4 | IPR017871 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.16e-04 | 18 | 141 | 3 | PS00754 | |
| Domain | Opioid_rcpt | 3.36e-04 | 4 | 141 | 2 | IPR001418 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.65e-04 | 45 | 141 | 4 | IPR018000 | |
| Domain | SNF | 3.74e-04 | 19 | 141 | 3 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 3.74e-04 | 19 | 141 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 3.74e-04 | 19 | 141 | 3 | PS50267 | |
| Domain | Na/ntran_symport | 3.74e-04 | 19 | 141 | 3 | IPR000175 | |
| Domain | Neur_chan_memb | 3.97e-04 | 46 | 141 | 4 | PF02932 | |
| Domain | IGc2 | 4.20e-04 | 235 | 141 | 8 | SM00408 | |
| Domain | Ig_sub2 | 4.20e-04 | 235 | 141 | 8 | IPR003598 | |
| Domain | Neur_chan_LBD | 4.32e-04 | 47 | 141 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.32e-04 | 47 | 141 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 4.32e-04 | 47 | 141 | 4 | IPR006029 | |
| Domain | - | 4.32e-04 | 47 | 141 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 4.32e-04 | 47 | 141 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.32e-04 | 47 | 141 | 4 | IPR006202 | |
| Domain | ABC_tran | 4.68e-04 | 48 | 141 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.68e-04 | 48 | 141 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.07e-04 | 49 | 141 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 5.48e-04 | 50 | 141 | 4 | IPR003439 | |
| Domain | Thbox_rcpt | 5.58e-04 | 5 | 141 | 2 | IPR001105 | |
| Domain | Prostanoid_rcpt | 1.54e-03 | 8 | 141 | 2 | IPR008365 | |
| Domain | 7TM_GPCR_Srsx | 1.60e-03 | 112 | 141 | 5 | SM01381 | |
| Domain | NPY_rcpt | 1.97e-03 | 9 | 141 | 2 | IPR000611 | |
| Domain | Ptc/Disp | 1.97e-03 | 9 | 141 | 2 | IPR003392 | |
| Domain | Patched | 1.97e-03 | 9 | 141 | 2 | PF02460 | |
| Domain | MFS_1 | 2.75e-03 | 77 | 141 | 4 | PF07690 | |
| Domain | MFS | 2.75e-03 | 77 | 141 | 4 | IPR011701 | |
| Domain | Olfact_rcpt | OR7E24 OR2W1 OR1D2 OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 3.02e-03 | 393 | 141 | 9 | IPR000725 |
| Domain | OA_transporter | 3.55e-03 | 12 | 141 | 2 | IPR004156 | |
| Domain | OATP | 3.55e-03 | 12 | 141 | 2 | PF03137 | |
| Domain | AA_permease_2 | 4.18e-03 | 13 | 141 | 2 | PF13520 | |
| Domain | SSD | 4.18e-03 | 13 | 141 | 2 | IPR000731 | |
| Domain | SSD | 4.18e-03 | 13 | 141 | 2 | PS50156 | |
| Domain | AA/rel_permease1 | 4.18e-03 | 13 | 141 | 2 | IPR002293 | |
| Domain | RasGAP | 4.85e-03 | 14 | 141 | 2 | SM00323 | |
| Domain | RasGAP_CS | 4.85e-03 | 14 | 141 | 2 | IPR023152 | |
| Domain | RasGAP | 5.57e-03 | 15 | 141 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 5.57e-03 | 15 | 141 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 5.57e-03 | 15 | 141 | 2 | PS50018 | |
| Domain | 2pore_dom_K_chnl | 5.57e-03 | 15 | 141 | 2 | IPR003280 | |
| Domain | - | 6.34e-03 | 16 | 141 | 2 | 1.10.506.10 | |
| Domain | Kringle | 7.15e-03 | 17 | 141 | 2 | IPR000001 | |
| Domain | Kringle_CS | 7.15e-03 | 17 | 141 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 7.15e-03 | 17 | 141 | 2 | PS50070 | |
| Domain | Kringle | 7.15e-03 | 17 | 141 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 7.15e-03 | 17 | 141 | 2 | PS00021 | |
| Domain | KR | 7.15e-03 | 17 | 141 | 2 | SM00130 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | CYSLTR2 GPR15 NPY5R MAS1L LPAR4 GPR31 OPN3 NTSR2 OR2W1 PTGER2 F2RL2 PTGFR OPRD1 OPRL1 OR1D2 OR11A1 P2RY2 PTGDR2 HRH3 | 3.42e-13 | 260 | 116 | 19 | M39397 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | VIPR1 CYSLTR2 OXER1 NPY5R LPAR4 GPR31 OPN3 NTSR2 TAS2R38 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 QRFPR TAS2R7 P2RY2 TAS2R31 TAS2R19 TAS2R46 PTGDR2 HRH3 | 2.96e-12 | 463 | 116 | 23 | M507 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | VIPR1 CYSLTR2 NPY5R LPAR4 GPR31 OPN3 NTSR2 TAS2R38 PTGER2 F2RL2 PTGFR OPRD1 OPRL1 QRFPR TAS2R7 P2RY2 TAS2R45 TAS2R31 TAS2R19 TAS2R46 PTGDR2 HRH3 | 5.25e-12 | 430 | 116 | 22 | MM15160 |
| Pathway | WP_GPCRS_NONODORANT | VIPR1 CYSLTR2 GPR15 NPY5R LPAR4 MRGPRD OPN3 NTSR2 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 QRFPR TAS2R7 P2RY2 HRH3 | 5.63e-11 | 266 | 116 | 17 | MM15843 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | VIPR1 CYSLTR2 GPR15 NPY5R LPAR4 GPR31 OPN3 NTSR2 TAS2R38 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 QRFPR TAS2R7 P2RY2 TAS2R45 TAS2R31 TAS2R19 TAS2R46 GPR176 PTGDR2 HRH3 | 6.73e-11 | 646 | 116 | 25 | MM14962 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 SLC29A2 SLC6A3 SLC6A13 SLC8B1 SLC30A5 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 SLC14A2 SLC4A9 | 2.00e-10 | 249 | 116 | 16 | M5988 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | VIPR1 CYSLTR2 OXER1 GPR15 NPY5R LPAR4 GPR31 OPN3 NTSR2 TAS2R38 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 QRFPR TAS2R7 P2RY2 TAS2R31 TAS2R19 TAS2R46 GPR176 PTGDR2 HRH3 | 3.89e-10 | 702 | 116 | 25 | M746 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | VIPR1 CYSLTR2 NPY5R LPAR4 NTSR2 PTGER2 F2RL2 PTGFR CHRNA2 CHRNA3 CHRNA5 CHRNB3 OPRD1 OPRL1 P2RY2 HRH3 | 7.34e-10 | 272 | 116 | 16 | M13380 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC29A2 SLC6A3 SLC6A13 SLC8B1 SLC30A5 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 SLC14A2 SLC4A9 | 1.01e-09 | 238 | 116 | 15 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 ABCA2 ABCA3 ATP7B TRPC4 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 SLC29A2 ABCA10 SLC6A3 SLC6A13 SLC8B1 CLCN1 SLC30A5 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 ANO7 SLC14A2 ATP4A SLC4A9 | 1.04e-09 | 736 | 116 | 25 | M27287 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CYSLTR2 OXER1 NPY5R LPAR4 GPR31 OPN3 NTSR2 PTGER2 F2RL2 PTGFR FFAR4 OPRD1 OPRL1 QRFPR P2RY2 PTGDR2 HRH3 | 1.58e-09 | 330 | 116 | 17 | M18334 |
| Pathway | WP_GPCRS_ODORANT | OR7E24 GPR31 GPR135 TAS2R38 OPRL1 MRGPRG TAS2R45 TAS2R31 TAS2R19 TAS2R46 GPR176 PTGDR2 | 6.06e-09 | 157 | 116 | 12 | MM15872 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 ABCA2 ABCA3 ATP7B TRPC4 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC29A2 SLC6A3 SLC6A13 SLC8B1 CLCN1 SLC30A5 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 ANO7 SLC14A2 ATP4A SLC4A9 | 6.06e-09 | 681 | 116 | 23 | MM14985 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CYSLTR2 NPY5R LPAR4 GPR31 OPN3 NTSR2 PTGER2 F2RL2 PTGFR OPRD1 OPRL1 QRFPR P2RY2 PTGDR2 HRH3 | 9.26e-08 | 333 | 116 | 15 | MM14963 |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 9.73e-08 | 15 | 116 | 5 | M10620 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.70e-07 | 31 | 116 | 6 | MM15691 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPY5R OPN3 NTSR2 PTGER2 F2RL2 PTGFR OPRD1 OPRL1 OR10D4P P2RY2 PTGDR2 | 3.70e-07 | 186 | 116 | 11 | MM15994 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 5.15e-07 | 37 | 116 | 6 | MM15067 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.31e-07 | 9 | 116 | 4 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.31e-07 | 9 | 116 | 4 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.37e-06 | 11 | 116 | 4 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.05e-06 | 12 | 116 | 4 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.05e-06 | 12 | 116 | 4 | MM15312 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 4.08e-06 | 52 | 116 | 6 | M5785 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 4.09e-06 | 14 | 116 | 4 | MM15012 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 4.09e-06 | 14 | 116 | 4 | M757 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | NPY5R GPR31 OPN3 TAS2R38 OPRD1 OPRL1 TAS2R7 TAS2R45 TAS2R31 TAS2R19 TAS2R46 PTGDR2 | 4.52e-06 | 289 | 116 | 12 | MM15057 |
| Pathway | REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY | 5.36e-06 | 5 | 116 | 3 | M27357 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 5.54e-06 | 15 | 116 | 4 | MM14704 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.72e-06 | 84 | 116 | 7 | M27334 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | OXER1 NPY5R GPR31 OPN3 TAS2R38 OPRD1 OPRL1 TAS2R7 TAS2R31 TAS2R19 TAS2R46 PTGDR2 | 1.05e-05 | 314 | 116 | 12 | M600 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.59e-05 | 39 | 116 | 5 | M793 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2W1 TAS2R38 OR1D2 TAS2R7 OR11A1 TAS2R45 TAS2R31 TAS2R19 TAS2R46 | 2.68e-05 | 190 | 116 | 9 | MM15687 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.73e-05 | 76 | 116 | 6 | MM15072 | |
| Pathway | REACTOME_PROSTANOID_LIGAND_RECEPTORS | 4.40e-05 | 9 | 116 | 3 | MM15014 | |
| Pathway | REACTOME_PROSTANOID_LIGAND_RECEPTORS | 4.40e-05 | 9 | 116 | 3 | M804 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 SLC6A13 KCNA5 KCNQ5 SLC22A1 KCNK2 | 9.86e-05 | 335 | 116 | 11 | MM14503 |
| Pathway | WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE | 1.03e-04 | 57 | 116 | 5 | M48332 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 2.30e-04 | 15 | 116 | 3 | M832 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 3.40e-04 | 210 | 116 | 8 | MM15043 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 3.49e-04 | 41 | 116 | 4 | MM15075 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 4.05e-04 | 18 | 116 | 3 | M524 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 4.19e-04 | 43 | 116 | 4 | M881 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 4.24e-04 | 217 | 116 | 8 | M18437 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.58e-04 | 44 | 116 | 4 | M11911 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 4.78e-04 | 19 | 116 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 4.78e-04 | 19 | 116 | 3 | MM15107 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CHRNA2 CHRNA3 KCNK4 CHRNA5 CHRNB3 SLC6A3 SLC6A13 KCNA5 KCNQ5 SLC22A1 KCNK2 | 5.72e-04 | 411 | 116 | 11 | M735 |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 5.91e-04 | 47 | 116 | 4 | M42524 | |
| Pathway | REACTOME_FREE_FATTY_ACID_RECEPTORS | 6.61e-04 | 5 | 116 | 2 | M27368 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 7.46e-04 | 22 | 116 | 3 | M22003 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 9.69e-04 | 24 | 116 | 3 | M18795 | |
| Pathway | WP_GPCRS_OTHER | 1.01e-03 | 93 | 116 | 5 | M39629 | |
| Pathway | WP_GPCRS_OTHER | 1.17e-03 | 96 | 116 | 5 | MM15939 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.79e-03 | 211 | 116 | 7 | MM14502 | |
| Pathway | REACTOME_NEUROTRANSMITTER_CLEARANCE | 1.82e-03 | 8 | 116 | 2 | MM14500 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.97e-03 | 108 | 116 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.05e-03 | 109 | 116 | 5 | MM15074 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR7E24 OR2W1 TAS2R38 OR1D2 TAS2R7 OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 TAS2R31 TAS2R46 OR52B2 | 2.18e-03 | 636 | 116 | 13 | M41834 |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.26e-03 | 32 | 116 | 3 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.47e-03 | 33 | 116 | 3 | M188 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.63e-03 | 70 | 116 | 4 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.38e-03 | 75 | 116 | 4 | M39696 | |
| Pathway | WP_ZINC_HOMEOSTASIS | 3.44e-03 | 37 | 116 | 3 | M39377 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 3.52e-03 | 11 | 116 | 2 | MM15049 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 3.52e-03 | 11 | 116 | 2 | M27184 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 3.52e-03 | 11 | 116 | 2 | MM15101 | |
| Pathway | REACTOME_NEUROTRANSMITTER_CLEARANCE | 3.52e-03 | 11 | 116 | 2 | M26914 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 3.52e-03 | 11 | 116 | 2 | MM14897 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 3.52e-03 | 11 | 116 | 2 | M39422 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 3.52e-03 | 11 | 116 | 2 | M930 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.52e-03 | 11 | 116 | 2 | MM15471 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 3.52e-03 | 11 | 116 | 2 | MM14547 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 4.20e-03 | 12 | 116 | 2 | M27728 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 4.20e-03 | 12 | 116 | 2 | M10960 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 4.20e-03 | 12 | 116 | 2 | MM15953 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 4.20e-03 | 12 | 116 | 2 | M1071 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 4.20e-03 | 12 | 116 | 2 | MM15476 | |
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 3.48e-10 | 22 | 146 | 6 | 12734386 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 4.70e-10 | 23 | 146 | 6 | 20022913 | |
| Pubmed | 8.18e-10 | 25 | 146 | 6 | 12139982 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 9.41e-10 | 12 | 146 | 5 | 12379855 | |
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 1.06e-09 | 26 | 146 | 6 | 11696554 | |
| Pubmed | 1.36e-09 | 27 | 146 | 6 | 12581520 | ||
| Pubmed | 1.52e-09 | 13 | 146 | 5 | 15938754 | ||
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 2.70e-09 | 30 | 146 | 6 | 12679530 | |
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 1.03e-08 | 7 | 146 | 4 | 1505988 | |
| Pubmed | 2.35e-08 | 21 | 146 | 5 | 10761934 | ||
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 8906617 | ||
| Pubmed | 6.14e-08 | 10 | 146 | 4 | 20736995 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 23943838 | ||
| Pubmed | 7.31e-08 | 179 | 146 | 9 | 18577758 | ||
| Pubmed | 8.57e-08 | 52 | 146 | 6 | 26590417 | ||
| Pubmed | 9.61e-08 | 11 | 146 | 4 | 12225896 | ||
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | 1.11e-07 | 28 | 146 | 5 | 15744053 | |
| Pubmed | 1.44e-07 | 12 | 146 | 4 | 20584212 | ||
| Pubmed | Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. | 1.59e-07 | 30 | 146 | 5 | 17273929 | |
| Pubmed | DNAJC13 ATP7B UBXN8 SREBF2 PIGU STK11IP TMEM161A NDC1 SLC30A5 TMEM106C ZDHHC13 ATP4A MAD2L1 | 2.35e-07 | 504 | 146 | 13 | 34432599 | |
| Pubmed | 2.89e-07 | 14 | 146 | 4 | 19059502 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 20840187 | ||
| Pubmed | 3.07e-07 | 34 | 146 | 5 | 15496549 | ||
| Pubmed | 3.21e-07 | 105 | 146 | 7 | 30280653 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 3.92e-07 | 15 | 146 | 4 | 8838678 | |
| Pubmed | 5.22e-07 | 16 | 146 | 4 | 19259974 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP7B CRIM1 OPN3 ROR1 CAV2 SLC7A6 PIGU STK11IP MFAP3L NDC1 SLC30A5 SLC16A6 TMEM106C TNFRSF1A PRAF2 ZDHHC13 ALG6 MFSD10 | 5.49e-07 | 1061 | 146 | 18 | 33845483 |
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 34852225 | ||
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 9193799 | ||
| Pubmed | Nicotinic acetylcholine receptors: from structure to brain function. | 7.20e-07 | 5 | 146 | 3 | 12783266 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.07e-06 | 79 | 146 | 6 | 12679517 | |
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 1.10e-06 | 19 | 146 | 4 | 17373692 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR7E24 OR2W1 OR1D2 OR10D4P OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 1.91e-06 | 340 | 146 | 10 | 11875048 |
| Pubmed | OR7E24 OR2W1 OR1D2 OR10D4P OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 1.91e-06 | 340 | 146 | 10 | 11802173 | |
| Pubmed | OR7E24 OR2W1 OR1D2 OR10D4P OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 2.07e-06 | 343 | 146 | 10 | 32295537 | |
| Pubmed | OR7E24 OR2W1 OR1D2 OR10D4P OR11A1 OR6C70 OR52H1 OR6C75 OR10W1 OR52B2 | 2.23e-06 | 346 | 146 | 10 | 14611657 | |
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 9009220 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 3.15e-06 | 95 | 146 | 6 | 16754659 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCA2 CRIM1 ROR2 EI24 SLC38A5 CAV2 PIGU CHRNA5 TMEM161A NDC1 TMEM106C SLC7A5 ALCAM SELENOI TNFRSF1A PRAF2 ZDHHC13 ALG6 | 3.16e-06 | 1201 | 146 | 18 | 35696571 |
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 17559419 | ||
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 24293640 | ||
| Pubmed | 5.40e-06 | 300 | 146 | 9 | 19086053 | ||
| Pubmed | 5.98e-06 | 9 | 146 | 3 | 17971500 | ||
| Pubmed | 5.98e-06 | 9 | 146 | 3 | 19228980 | ||
| Pubmed | 6.52e-06 | 29 | 146 | 4 | 20167577 | ||
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 10336173 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.11e-05 | 118 | 146 | 6 | 19156168 | |
| Pubmed | Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. | 1.17e-05 | 11 | 146 | 3 | 29791835 | |
| Pubmed | A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. | 1.17e-05 | 11 | 146 | 3 | 11551509 | |
| Pubmed | 1.66e-05 | 75 | 146 | 5 | 2834384 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 16636285 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 29993116 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 31599127 | ||
| Pubmed | Identification of ligands for two human bitter T2R receptors. | 1.75e-05 | 2 | 146 | 2 | 15337684 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 16901265 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10684792 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 34763666 | ||
| Pubmed | ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. | 1.75e-05 | 2 | 146 | 2 | 15649702 | |
| Pubmed | The involvement of L-type amino acid transporters in theanine transport. | 1.75e-05 | 2 | 146 | 2 | 23221699 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 18957677 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21586796 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28552880 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11559713 | ||
| Pubmed | CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population. | 1.75e-05 | 2 | 146 | 2 | 29609626 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 38019257 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 1282354 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22060278 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19782748 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19913791 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11713269 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22529353 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19132693 | ||
| Pubmed | The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation. | 1.75e-05 | 2 | 146 | 2 | 34155901 | |
| Pubmed | Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies. | 1.75e-05 | 2 | 146 | 2 | 22988987 | |
| Pubmed | Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. | 1.75e-05 | 2 | 146 | 2 | 18227835 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21385908 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20564069 | ||
| Pubmed | CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers. | 1.75e-05 | 2 | 146 | 2 | 26751916 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 37430307 | ||
| Pubmed | In vivo RNA-RNA duplexes from human alpha3 and alpha5 nicotinic receptor subunit mRNAs. | 1.75e-05 | 2 | 146 | 2 | 15716100 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10231392 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27127891 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25051068 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10970803 | ||
| Pubmed | A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. | 1.75e-05 | 2 | 146 | 2 | 20395203 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 38587578 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 12898527 | ||
| Pubmed | Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. | 1.75e-05 | 2 | 146 | 2 | 11429290 | |
| Pubmed | TREK-1, a K+ channel involved in neuroprotection and general anesthesia. | 1.75e-05 | 2 | 146 | 2 | 15175651 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21822716 | ||
| Pubmed | Cloning of two novel ABC transporters mapping on human chromosome 9. | 1.75e-05 | 2 | 146 | 2 | 8088782 | |
| Pubmed | Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. | 1.75e-05 | 2 | 146 | 2 | 19902402 | |
| Pubmed | A novel family of cell surface receptors with tyrosine kinase-like domain. | 1.75e-05 | 2 | 146 | 2 | 1334494 | |
| Pubmed | A twin association study of nicotine dependence with markers in the CHRNA3 and CHRNA5 genes. | 1.75e-05 | 2 | 146 | 2 | 21748402 | |
| Pubmed | Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine. | 1.75e-05 | 2 | 146 | 2 | 36078193 | |
| Pubmed | CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women. | 1.75e-05 | 2 | 146 | 2 | 24588897 | |
| Pubmed | Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. | 1.75e-05 | 2 | 146 | 2 | 15654020 | |
| Pubmed | Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains. | 1.75e-05 | 2 | 146 | 2 | 25029443 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 9624109 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20725741 | ||
| Interaction | TSPAN15 interactions | ABCA2 PCNX3 EI24 SLC38A5 SLC7A6 PIGU MFAP3 TMEM161A FADS1 NDC1 ZDHHC13 | 1.66e-06 | 276 | 129 | 11 | int:TSPAN15 |
| Interaction | CHRNB2 interactions | 4.45e-06 | 103 | 129 | 7 | int:CHRNB2 | |
| Interaction | PTH1R interactions | 2.16e-05 | 88 | 129 | 6 | int:PTH1R | |
| Interaction | YIPF5 interactions | 2.38e-05 | 133 | 129 | 7 | int:YIPF5 | |
| Interaction | DOLK interactions | 2.68e-05 | 55 | 129 | 5 | int:DOLK | |
| Interaction | ABCA6 interactions | 2.98e-05 | 10 | 129 | 3 | int:ABCA6 | |
| Interaction | YIPF4 interactions | 7.50e-05 | 68 | 129 | 5 | int:YIPF4 | |
| Interaction | ZNRF4 interactions | 7.61e-05 | 110 | 129 | 6 | int:ZNRF4 | |
| Interaction | P2RY2 interactions | 8.41e-05 | 112 | 129 | 6 | int:P2RY2 | |
| Interaction | FCER1A interactions | 8.98e-05 | 37 | 129 | 4 | int:FCER1A | |
| Interaction | RHOB interactions | DAB2IP CRIM1 PCNX3 ROR2 SLCO4A1 SLC38A5 CAV2 SLC7A6 STK11IP MFAP3 NDC1 DDX18 SLC7A5 ALCAM PRAF2 TSR3 | 9.38e-05 | 840 | 129 | 16 | int:RHOB |
| Interaction | YIPF6 interactions | 1.07e-04 | 117 | 129 | 6 | int:YIPF6 | |
| Interaction | MS4A15 interactions | 1.11e-04 | 39 | 129 | 4 | int:MS4A15 | |
| Interaction | C3orf52 interactions | 1.55e-04 | 305 | 129 | 9 | int:C3orf52 | |
| Interaction | NRAS interactions | DAB2IP RASA1 ROR1 ROR2 UBXN8 EI24 SLCO4A1 PIGU TMEM161A PIEZO2 NDC1 SLC30A5 SLC7A5 ZDHHC13 | 1.58e-04 | 699 | 129 | 14 | int:NRAS |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | CD163 SLC6A13 CLEC4E TAS2R7 KCNA5 TAS2R31 TNFRSF1A TAS2R19 TAS2R46 | 1.94e-06 | 353 | 144 | 9 | chr12p13 |
| Cytoband | 12p13.2 | 1.25e-05 | 45 | 144 | 4 | 12p13.2 | |
| Cytoband | 8p11.2 | 8.67e-04 | 14 | 144 | 2 | 8p11.2 | |
| Cytoband | 15q24 | 1.97e-03 | 21 | 144 | 2 | 15q24 | |
| Cytoband | 20q13.33 | 2.01e-03 | 79 | 144 | 3 | 20q13.33 | |
| Cytoband | 4q27 | 2.17e-03 | 22 | 144 | 2 | 4q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 3.21e-03 | 454 | 144 | 6 | chr11q13 | |
| Cytoband | 12p13.3 | 4.01e-03 | 30 | 144 | 2 | 12p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p11 | 4.25e-03 | 103 | 144 | 3 | chr8p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q27 | 4.56e-03 | 32 | 144 | 2 | chr4q27 | |
| GeneFamily | Solute carriers | SLC6A16 SLC30A8 SLCO4A1 SLC38A5 SLC7A6 SLC30A2 SLC29A2 SLC6A3 SLC6A13 SLC8B1 SLC30A5 SLC16A6 SLC22A14 SLCO2A1 SLC22A1 SLC28A2 SLC7A5 SLC14A2 SLC4A9 | 8.93e-12 | 395 | 117 | 19 | 752 |
| GeneFamily | Taste 2 receptors | 5.14e-09 | 39 | 117 | 7 | 1162 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 7.17e-07 | 78 | 117 | 7 | 262 | |
| GeneFamily | ATP binding cassette subfamily A | 1.59e-06 | 14 | 117 | 4 | 805 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.85e-06 | 16 | 117 | 4 | 173 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 2.16e-05 | 9 | 117 | 3 | 207 | |
| GeneFamily | Opioid receptors | 2.47e-04 | 4 | 117 | 2 | 245 | |
| GeneFamily | Leukotriene receptors | 6.12e-04 | 6 | 117 | 2 | 204 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.81e-03 | 10 | 117 | 2 | 830 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.96e-03 | 161 | 117 | 5 | 593 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 4.13e-03 | 15 | 117 | 2 | 277 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 8.05e-03 | 21 | 117 | 2 | 680 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-06 | 165 | 142 | 7 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.07e-06 | 166 | 142 | 7 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.79e-06 | 114 | 142 | 6 | 1c99483a492d08b6bb745006fe24c22841dc57ad | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.79e-06 | 123 | 142 | 6 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.58e-06 | 199 | 142 | 7 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.55e-06 | 82 | 142 | 5 | 51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.42e-06 | 149 | 142 | 6 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 165 | 142 | 6 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 165 | 142 | 6 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.56e-05 | 166 | 142 | 6 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.78e-05 | 170 | 142 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 173 | 142 | 6 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 173 | 142 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 175 | 142 | 6 | 046e841811b22c39f80a9752f3223c1906de6f20 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Scn4b_(Globus_Pallidus_Externus_(GP),_"Prototypical")--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.12e-05 | 51 | 142 | 4 | 74d7932d0e7363c00117890747980b4b04ff4524 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Scn4b_(Globus_Pallidus_Externus_(GP),_"Prototypical")-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.12e-05 | 51 | 142 | 4 | 88597bef58fe807b65da34925e863e7fbe3a7e3e | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Scn4b_(Globus_Pallidus_Externus_(GP),_"Prototypical")|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.12e-05 | 51 | 142 | 4 | 91e17b1a85e2b5c507c64f39f322a5a9b7bf30bd | |
| ToppCell | facs-Heart-LV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 176 | 142 | 6 | 483e36d9bb7268bf179e69a65e1a0be099035162 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 179 | 142 | 6 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 179 | 142 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 181 | 142 | 6 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 181 | 142 | 6 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 2.54e-05 | 181 | 142 | 6 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 2.54e-05 | 181 | 142 | 6 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-05 | 183 | 142 | 6 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2-Th.Adora2a-Th_(Striatum,_Th+_SPN)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 56 | 142 | 4 | e6b2f6ff08887ae8335c44d7fff118c371768809 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2-Th.Adora2a-Th_(Striatum,_Th+_SPN)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 56 | 142 | 4 | 7a1f39e2ebe70d757847e4fb02c39313b1ea5a2d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-05 | 190 | 142 | 6 | e59e3ad044af7b4409d5ecbd326fe83862e5fc9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 190 | 142 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 190 | 142 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 193 | 142 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 194 | 142 | 6 | bb36274d6fe2d18c545a17d3809f331586502d01 | |
| ToppCell | medial-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 194 | 142 | 6 | d58be6454a0795d6771036a1620553a153861615 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 194 | 142 | 6 | 0117cd68750153fd6b8978c8b4ce3589486d2b5f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 197 | 142 | 6 | 86591849476b3925857a82b6913f65e74df200c1 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 197 | 142 | 6 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 197 | 142 | 6 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-05 | 198 | 142 | 6 | 3aae7d146ebbb34da3239041a7c0334abff2597f | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 198 | 142 | 6 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-05 | 198 | 142 | 6 | 9ecf944984aade1bf902e3a92ea4d46a3696822f | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.31e-05 | 199 | 142 | 6 | 9364199c5b4540ce2e14341fd9d504b695f8249d | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.31e-05 | 199 | 142 | 6 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.31e-05 | 199 | 142 | 6 | 1621ce2968f3100e4c39e0ef8293232a5d76c614 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.31e-05 | 199 | 142 | 6 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-05 | 199 | 142 | 6 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-05 | 199 | 142 | 6 | 82758d0cee9387d002e3f68a6faa324134fb7564 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.31e-05 | 199 | 142 | 6 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.43e-05 | 200 | 142 | 6 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 200 | 142 | 6 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 200 | 142 | 6 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.43e-05 | 200 | 142 | 6 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.43e-05 | 200 | 142 | 6 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.43e-05 | 200 | 142 | 6 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 200 | 142 | 6 | 16a70cc07dcfb4eba4385b712f27010c6629ff67 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.43e-05 | 200 | 142 | 6 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.60e-05 | 62 | 142 | 4 | 02f0398e18bd61fbfa03bce71ae77e106181abee | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.60e-05 | 62 | 142 | 4 | 8fdbced7a2baa1bfb5b1e204128234424a872fe6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.60e-05 | 62 | 142 | 4 | ff68e007b8b2af4c7fb09139aed92e86907a05da | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.24e-05 | 126 | 142 | 5 | 84dce108561d4b745d19250c2ac0667d9e4ea17d | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.03e-05 | 134 | 142 | 5 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.03e-05 | 134 | 142 | 5 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.03e-05 | 134 | 142 | 5 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.03e-05 | 134 | 142 | 5 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 70 | 142 | 4 | c6d3f8cd3f79e2beb826b07a6b9f3ab35d4f23ea | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 70 | 142 | 4 | 823921f8bf585d45f24f627b2b77b228898eb85a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 70 | 142 | 4 | d2be16550c572ba77261c978648e61dba3eab6bd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 70 | 142 | 4 | 52bde49a05f2387fe3e4357422e155bee2e86ae6 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-05 | 139 | 142 | 5 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-04 | 146 | 142 | 5 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 148 | 142 | 5 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 1.20e-04 | 150 | 142 | 5 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 150 | 142 | 5 | d6b977dd47aa017f6ba762f0c505cd896caa523f | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 153 | 142 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 155 | 142 | 5 | efe69145910c5e049d0ed30699c26ef963e0a285 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 155 | 142 | 5 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | droplet-Liver-Npc-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 155 | 142 | 5 | d883a3869cf893d62741f26f641ed3923aba03f9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.39e-04 | 155 | 142 | 5 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 155 | 142 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-04 | 156 | 142 | 5 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 158 | 142 | 5 | 3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-04 | 159 | 142 | 5 | 4750ba9ca06ed97b18df3c74eeb51d3ac8763f63 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 85 | 142 | 4 | 67336aa7ec02b64595ce7d5222d43cead92eb52e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 85 | 142 | 4 | a7a5d82924cd4a41ab87b1abf13143635882a4b2 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 85 | 142 | 4 | 86c5d71b66ff55c44d2d457865dda72e07e5ec53 | |
| ToppCell | LAM-Lymphoid-B-cell-2|LAM / Condition, Lineage and Cell class | 1.62e-04 | 160 | 142 | 5 | 0060c2b3304f411c682aa2ba20bcf80f346d2403 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 161 | 142 | 5 | 8e787cc7f5e818cad1a6ed143a5fe310993e030b | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 161 | 142 | 5 | ca9233370490e27b9a1892669d6b82db2136180e | |
| ToppCell | severe-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.66e-04 | 161 | 142 | 5 | 9e8e8ac11f7fb8c8697357c21034b613f191db2b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 162 | 142 | 5 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 162 | 142 | 5 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | ILEUM-non-inflamed-(3)_pDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.76e-04 | 163 | 142 | 5 | bc5411702badab39143905aa51676b4bbfad2041 | |
| ToppCell | -Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-04 | 164 | 142 | 5 | 2d65f025f921a5327bfd8d260815baaed00ef3fa | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-04 | 165 | 142 | 5 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-04 | 165 | 142 | 5 | e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 1.92e-04 | 166 | 142 | 5 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 168 | 142 | 5 | 22fa707689e8d6ca5154103b7374007d644d61c3 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 169 | 142 | 5 | 4126b20df9e85f028807482a51e20a300faa74c2 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 169 | 142 | 5 | 818ab7a6fd1940a22d3bd99fe15f0af888af6b3e | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 169 | 142 | 5 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| Computational | Membranal receptors. | VIPR1 ABCA1 ATP7B ROR1 ROR2 ITGA10 NTSR2 SLC29A2 CHRNA2 CD163 CHRNB3 SLC6A3 FCER1A CD79A ATP4A | 5.99e-06 | 517 | 81 | 15 | MODULE_64 |
| Computational | Genes in the cancer module 27. | VIPR1 ROR1 ROR2 ITGA10 PTGER2 PTGFR CHRNA2 CHRNA3 CD163 CHRNB3 FCER1A CD79A | 1.27e-05 | 355 | 81 | 12 | MODULE_27 |
| Computational | AcetylCholine receptors. | 1.41e-04 | 14 | 81 | 3 | MODULE_328 | |
| Computational | Genes in the cancer module 267. | 1.76e-04 | 15 | 81 | 3 | MODULE_267 | |
| Computational | Neighborhood of LCAT | 4.87e-04 | 133 | 81 | 6 | MORF_LCAT | |
| Drug | sodium | ATP7B SLC6A16 TRPC4 COX6A2 SLCO4A1 SLC38A5 DUOX2 SLC7A6 SLC29A2 CHRNA2 CHRNA3 OPRD1 SLC6A3 SLC6A13 SLC8B1 KCNA5 P2RY2 KCNK2 SLC28A2 SLC7A5 SLC14A2 ATP4A SLC4A9 | 1.84e-08 | 944 | 141 | 23 | CID000000923 |
| Drug | glibenclamide | ABCA1 ABCA2 ABCA3 ATP7B SLC30A8 ABCA10 KCNK4 OPRD1 OPRL1 CLCN1 KCNA5 KCNQ5 P2RY2 KCNK2 | 1.16e-07 | 382 | 141 | 14 | CID000003488 |
| Drug | neuroNal | 5.69e-07 | 49 | 141 | 6 | CID000010535 | |
| Drug | myo-inositol | DAB2IP DPAGT1 VIPR1 LPAR4 RASA1 TRPC4 NTSR2 PTGER2 PTGFR CHRNA2 CHRNA3 CHRNB3 OPRD1 FCER1A P2RY2 CD79A GPR176 HRH3 | 2.83e-06 | 811 | 141 | 18 | CID000000892 |
| Drug | sipatrigine | 3.15e-06 | 37 | 141 | 5 | CID000060803 | |
| Drug | desloratadine | 4.41e-06 | 69 | 141 | 6 | CID000124087 | |
| Drug | decamethonium | 4.59e-06 | 6 | 141 | 3 | ctd:C033019 | |
| Drug | hemicholinium-3 | 9.03e-06 | 78 | 141 | 6 | CID000003585 | |
| Drug | LS-63783 | CYSLTR2 OXER1 CYP26A1 NTSR2 SLC38A5 PTGER2 PTGFR CHRNA2 CHRNA3 KCNK4 FADS1 CLCN1 FCER1A KCNA5 P2RY2 KCNK2 PTGDR2 | 1.03e-05 | 804 | 141 | 17 | CID000000231 |
| Drug | AC1L1KSK | 1.14e-05 | 23 | 141 | 4 | CID000005636 | |
| Drug | Dimethylphenylpiperazinium Iodide | 1.27e-05 | 8 | 141 | 3 | ctd:D004246 | |
| Drug | epibatidine | 1.27e-05 | 8 | 141 | 3 | ctd:C082748 | |
| Drug | tetradotoxin | VIPR1 LPAR4 MRGPRD COX6A2 NTSR2 CHRNA2 CHRNA3 CHRNB3 OPRD1 OPRL1 SLC6A13 HRH3 | 1.50e-05 | 428 | 141 | 12 | CID000020382 |
| Drug | mecamylamine | 1.93e-05 | 89 | 141 | 6 | CID000004032 | |
| Drug | Bd 737 | 2.70e-05 | 10 | 141 | 3 | CID000131252 | |
| Drug | benzodiazepine | 2.98e-05 | 142 | 141 | 7 | CID000134664 | |
| Drug | hexamethonium | 3.12e-05 | 143 | 141 | 7 | CID000003604 | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; HL60; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 2991_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 6664_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 7519_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 2259_UP | |
| Drug | PGF1|A | 3.41e-05 | 30 | 141 | 4 | CID000004957 | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 3.47e-05 | 199 | 141 | 8 | 61_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.60e-05 | 200 | 141 | 8 | 6095_UP | |
| Drug | Dns-C6-Cho | 3.70e-05 | 11 | 141 | 3 | CID000124728 | |
| Drug | AC1L9NC9 | 3.70e-05 | 11 | 141 | 3 | CID000449642 | |
| Drug | cytisine | 3.70e-05 | 11 | 141 | 3 | ctd:C004712 | |
| Drug | dihydronereistoxin | 3.70e-05 | 11 | 141 | 3 | CID000121232 | |
| Drug | LJP 1082 | 3.70e-05 | 11 | 141 | 3 | CID003037609 | |
| Drug | bipinnatin-B | 3.70e-05 | 11 | 141 | 3 | CID000127363 | |
| Drug | 4-iodobenzoylchloride | 3.81e-05 | 2 | 141 | 2 | CID000074373 | |
| Drug | aspirin chloride | 3.81e-05 | 2 | 141 | 2 | CID000079668 | |
| Drug | Ultracet | 4.82e-05 | 64 | 141 | 5 | CID000005523 | |
| Drug | AC1L9P8C | 4.91e-05 | 12 | 141 | 3 | CID000450864 | |
| Drug | SureCN373116 | 4.91e-05 | 12 | 141 | 3 | CID010085732 | |
| Drug | benzilate | 5.60e-05 | 66 | 141 | 5 | CID000201538 | |
| Drug | l-Lobeline | 5.66e-05 | 34 | 141 | 4 | CID000003945 | |
| Drug | atropine sulfate | VIPR1 ATP7B CHRNA2 CHRNA3 CHRNB3 OPRD1 OPRL1 CLCN1 CD79A HRH3 | 6.28e-05 | 347 | 141 | 10 | CID000003661 |
| Drug | nereistoxin | 6.35e-05 | 13 | 141 | 3 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 6.35e-05 | 13 | 141 | 3 | CID004392675 | |
| Drug | C-toxiferine-I | 6.35e-05 | 13 | 141 | 3 | CID005089093 | |
| Drug | bipinnatin-A | 6.35e-05 | 13 | 141 | 3 | CID000196603 | |
| Drug | MB28767 | 6.35e-05 | 13 | 141 | 3 | CID005311223 | |
| Drug | bipinnatin-C | 6.35e-05 | 13 | 141 | 3 | CID000129977 | |
| Drug | gallamine | 6.36e-05 | 35 | 141 | 4 | CID000003450 | |
| Drug | (+/-)-Epibatidine | 6.36e-05 | 35 | 141 | 4 | CID000001204 | |
| Drug | methacholine | 6.40e-05 | 217 | 141 | 8 | CID000001993 | |
| Drug | Heptachlor | 6.73e-05 | 111 | 141 | 6 | ctd:D006533 | |
| Drug | quindine | 6.82e-05 | 219 | 141 | 8 | CID000001065 | |
| Drug | phenylquinone | 7.12e-05 | 36 | 141 | 4 | CID000009688 | |
| Drug | ether | 7.44e-05 | 113 | 141 | 6 | CID000003283 | |
| Drug | 2,3-dichlorooctafluorobutane | 8.05e-05 | 14 | 141 | 3 | CID000078982 | |
| Drug | LNF 209 | 8.05e-05 | 14 | 141 | 3 | CID000132666 | |
| Drug | anatoxin-a hydrochloride | 1.00e-04 | 15 | 141 | 3 | CID000135265 | |
| Drug | SAD-128 | 1.00e-04 | 15 | 141 | 3 | CID000162008 | |
| Drug | N-methylcytisine | 1.00e-04 | 15 | 141 | 3 | CID000234566 | |
| Drug | ZK110841 | 1.00e-04 | 15 | 141 | 3 | CID005311503 | |
| Drug | aa373 | 1.00e-04 | 15 | 141 | 3 | CID000191672 | |
| Drug | (-)-pictamine | 1.00e-04 | 15 | 141 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 1.00e-04 | 15 | 141 | 3 | CID006918624 | |
| Drug | UB-165 | 1.00e-04 | 15 | 141 | 3 | CID004694339 | |
| Drug | AC1L1EIK | 1.08e-04 | 40 | 141 | 4 | CID000002807 | |
| Drug | Enkephalin, Leucine-2-Alanine | 1.14e-04 | 3 | 141 | 2 | ctd:D016308 | |
| Drug | NSC11411 | 1.14e-04 | 3 | 141 | 2 | CID000408117 | |
| Drug | Ro 64-6198 | 1.14e-04 | 3 | 141 | 2 | CID009844019 | |
| Drug | BW245C | 1.19e-04 | 41 | 141 | 4 | CID000119304 | |
| Drug | Hexamethonium | 1.23e-04 | 16 | 141 | 3 | ctd:D018738 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 1.23e-04 | 16 | 141 | 3 | CID000123866 | |
| Drug | AC1L2SVN | 1.23e-04 | 16 | 141 | 3 | CID000127922 | |
| Drug | benzoquinonium | 1.23e-04 | 16 | 141 | 3 | CID000009393 | |
| Drug | PNU-282,987 | 1.23e-04 | 16 | 141 | 3 | CID004655349 | |
| Drug | AC1L1BQX | 1.32e-04 | 79 | 141 | 5 | CID000001565 | |
| Drug | Nsc36388 | 1.48e-04 | 17 | 141 | 3 | CID000014954 | |
| Drug | bupropion | 1.49e-04 | 81 | 141 | 5 | CID000000444 | |
| Drug | AC1L1JJR | 1.58e-04 | 44 | 141 | 4 | CID000005072 | |
| Drug | AC1O8PVM | 1.77e-04 | 18 | 141 | 3 | CID000004989 | |
| Drug | ABT-594 | 1.77e-04 | 18 | 141 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 1.77e-04 | 18 | 141 | 3 | CID000656712 | |
| Drug | benzetimide | 1.77e-04 | 18 | 141 | 3 | CID000021846 | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; PC3; HT_HG-U133A | 1.86e-04 | 190 | 141 | 7 | 4563_UP | |
| Drug | ipratropium bromide | 1.88e-04 | 46 | 141 | 4 | CID000003746 | |
| Drug | AC1L9P88 | 2.09e-04 | 19 | 141 | 3 | CID000450860 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 2.09e-04 | 19 | 141 | 3 | CID000162425 | |
| Drug | isoarecolone | 2.09e-04 | 19 | 141 | 3 | CID000146970 | |
| Drug | beta-erythroidine | 2.09e-04 | 19 | 141 | 3 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 2.09e-04 | 19 | 141 | 3 | CID000107881 | |
| Drug | PNU-120596 | 2.09e-04 | 19 | 141 | 3 | CID000311434 | |
| Drug | AC1Q3ZOL | 2.11e-04 | 258 | 141 | 8 | CID000002376 | |
| Drug | beta-erythroidine | 2.27e-04 | 4 | 141 | 2 | ctd:C004873 | |
| Drug | Phe-Gly-Gly-Phe | 2.27e-04 | 4 | 141 | 2 | CID003327925 | |
| Drug | latanoprost | 2.27e-04 | 4 | 141 | 2 | ctd:C072042 | |
| Drug | alpha-conotoxin MII | 2.27e-04 | 4 | 141 | 2 | ctd:C098872 | |
| Drug | pyrrole-2,3,5-tricarboxylic acid | 2.27e-04 | 4 | 141 | 2 | ctd:C071226 | |
| Drug | raloxifene hydrochloride; Up 200; 0.1uM; HL60; HG-U133A | 2.32e-04 | 197 | 141 | 7 | 388_UP | |
| Drug | AC1L9NAZ | 2.39e-04 | 198 | 141 | 7 | CID000449606 | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.39e-04 | 198 | 141 | 7 | 7375_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 2.39e-04 | 198 | 141 | 7 | 5595_UP | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.39e-04 | 198 | 141 | 7 | 5682_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.39e-04 | 198 | 141 | 7 | 5644_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.39e-04 | 198 | 141 | 7 | 6034_UP | |
| Disease | alcohol use disorder (implicated_via_orthology) | VIPR1 NPY5R RASA1 SREBF2 CHRNA2 CHRNA3 CHRNB3 OPRL1 FADS1 PRAF2 | 1.69e-08 | 195 | 130 | 10 | DOID:1574 (implicated_via_orthology) |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.73e-07 | 12 | 130 | 4 | C1861063 | |
| Disease | nicotine dependence (is_implicated_in) | 1.66e-06 | 6 | 130 | 3 | DOID:0050742 (is_implicated_in) | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.18e-05 | 32 | 130 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | Alcohol abuse | 1.19e-05 | 67 | 130 | 5 | C0085762 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.51e-05 | 34 | 130 | 4 | DOID:11832 (implicated_via_orthology) | |
| Disease | Smoking as a quantitative trait locus 3 | 1.93e-05 | 2 | 130 | 2 | cv:C3150168 | |
| Disease | – | 1.93e-05 | 2 | 130 | 2 | 612052 | |
| Disease | Asthma, Aspirin-Induced | 2.31e-05 | 13 | 130 | 3 | C1319853 | |
| Disease | Alcoholic Intoxication, Chronic | 2.61e-05 | 268 | 130 | 8 | C0001973 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 4.49e-05 | 16 | 130 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | systemic mastocytosis | 1.79e-04 | 25 | 130 | 3 | MONDO_0016586 | |
| Disease | Colorectal Neoplasms | 2.36e-04 | 277 | 130 | 7 | C0009404 | |
| Disease | hip bone mineral density | 2.45e-04 | 126 | 130 | 5 | EFO_0007702 | |
| Disease | lung cancer (is_implicated_in) | 3.26e-04 | 74 | 130 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | Cocaine Dependence | 3.85e-04 | 139 | 130 | 5 | C0600427 | |
| Disease | obesity (biomarker_via_orthology) | 4.98e-04 | 147 | 130 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | time to first cigarette measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0010126 | |
| Disease | obesity (is_implicated_in) | 7.15e-04 | 91 | 130 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | DPAGT1 ABCA3 CATSPERE ATP7B TRPC4 ROR1 SREBF2 PKDREJ SLC6A3 TMEM161A CLCN1 KCNA5 DDX18 | 9.40e-04 | 1074 | 130 | 13 | C0006142 |
| Disease | Alcohol Use Disorder | 9.70e-04 | 44 | 130 | 3 | C0001956 | |
| Disease | pigmentation disease (is_implicated_in) | 1.03e-03 | 11 | 130 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | rhinitis (is_marker_for) | 1.10e-03 | 46 | 130 | 3 | DOID:4483 (is_marker_for) | |
| Disease | Lung Neoplasms | 1.17e-03 | 265 | 130 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.19e-03 | 266 | 130 | 6 | C0242379 | |
| Disease | Tobacco Dependence | 1.69e-03 | 14 | 130 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 1.69e-03 | 14 | 130 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 1.69e-03 | 14 | 130 | 2 | C0376384 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.82e-03 | 117 | 130 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.84e-03 | 197 | 130 | 5 | EFO_0005680 | |
| Disease | HOMA-B | 1.85e-03 | 55 | 130 | 3 | EFO_0004469 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.87e-03 | 118 | 130 | 4 | EFO_0010119 | |
| Disease | high grade glioma (biomarker_via_orthology) | 1.95e-03 | 15 | 130 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | diffuse idiopathic skeletal hyperostosis | 1.95e-03 | 15 | 130 | 2 | EFO_0007236 | |
| Disease | Withdrawal Symptoms | 2.16e-03 | 58 | 130 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.16e-03 | 58 | 130 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.16e-03 | 58 | 130 | 3 | C0038587 | |
| Disease | lung small cell carcinoma (is_marker_for) | 2.22e-03 | 16 | 130 | 2 | DOID:5409 (is_marker_for) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.45e-03 | 307 | 130 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 2.51e-03 | 17 | 130 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Hypercholesterolemia, Familial | 2.81e-03 | 18 | 130 | 2 | C0020445 | |
| Disease | eye colour measurement | 2.85e-03 | 218 | 130 | 5 | EFO_0009764 | |
| Disease | emphysema pattern measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0005850 | |
| Disease | glomerulonephritis (is_marker_for) | 3.14e-03 | 19 | 130 | 2 | DOID:2921 (is_marker_for) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.20e-03 | 224 | 130 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.39e-03 | 139 | 130 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | X-24309 measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0800872 | |
| Disease | cholesterol in very large HDL measurement | 3.54e-03 | 69 | 130 | 3 | EFO_0022229 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 3.83e-03 | 21 | 130 | 2 | OBA_2045104 | |
| Disease | smoking behavior | 4.10e-03 | 341 | 130 | 6 | EFO_0004318 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 4.31e-03 | 74 | 130 | 3 | DOID:3748 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESPTLLCVALLFFAP | 6 | P12319 | |
| IIPCLGLSFLTVLVF | 241 | Q05901 | |
| LTEVSLPSRFFCLLL | 256 | Q96Q91 | |
| VIATVPLFFCIIAPF | 1301 | Q9P2K9 | |
| CFIADFLILLTFPLL | 206 | Q5SY80 | |
| PCLLISFLTVLVFYL | 251 | P32297 | |
| SIFLLLITNCVSPFI | 936 | Q8WWZ4 | |
| LPDLFSVLVCFVSCL | 466 | Q9Y672 | |
| LFIPFFIIFCVLIAI | 691 | Q99965 | |
| GLSILNLIFFILCTF | 691 | P35670 | |
| SLVALIFTFFVPLLS | 196 | P49685 | |
| LSCLQFVLPFGLIVF | 181 | O00270 | |
| IVLPAVFVCIALVFS | 1351 | O95477 | |
| CLLISCLTVLVFYLP | 276 | Q15822 | |
| SDPSLVLAFLLCFAI | 341 | Q99758 | |
| ILLFCAVVPGTLLLF | 151 | P11912 | |
| LLVFLFAPVVSDLCS | 6 | A6H8M9 | |
| LLLATLLVFLCFFTA | 6 | P42127 | |
| VSGFVFLRLICPAIL | 896 | P20936 | |
| SLALSDLLITFFCIP | 86 | Q96P65 | |
| LVFLVGCFLVFSDIP | 366 | Q6IWH7 | |
| FLEISFTTACIPRFL | 66 | A6NIJ9 | |
| LISASLFLRFLCPAI | 516 | Q5VWQ8 | |
| LLLYSFAAAVVVPCL | 366 | Q14728 | |
| LSLQLVAFIFSLPFC | 146 | Q8NGF6 | |
| LILSVFCLTIPFGLI | 201 | Q9GZK7 | |
| VGLLSLICFFLILVS | 201 | Q8NGN7 | |
| CFLPSVPFLILVSTL | 11 | O75121 | |
| FLPLLEVSCSFDLLI | 141 | Q13257 | |
| VFCSVTILSFPAIAL | 126 | Q14439 | |
| LLLPLLTFCTVSEAS | 6 | A0A075B6K4 | |
| VLVSFVLPLALTAFL | 211 | O95665 | |
| LLIGCLLFVLTPTFV | 176 | Q9NYG8 | |
| LAVSDLLFVCTLPFK | 81 | Q99677 | |
| LVFGCLILSVFSTIP | 136 | Q9NR82 | |
| LFGCVLFVALPAIIF | 231 | O95069 | |
| IFSVSPLSLLACIFP | 1151 | Q9NRD8 | |
| ISGAVFLIILFCFIP | 61 | Q9H3H5 | |
| LFCADLLFISAIPLV | 81 | Q5NUL3 | |
| LSGVCLFAVFIALLP | 156 | P43088 | |
| VPVLFSVFCGLLVAL | 981 | Q9H6A9 | |
| LSFLDLCFTTSIIPQ | 66 | Q9Y3N9 | |
| IALAVITRSFCIIFP | 146 | Q96RD2 | |
| ITRSFCIIFPVIFLL | 151 | Q96RD2 | |
| VLPVIYAVSLLFCSL | 156 | P43116 | |
| SCAPLLLLFSFQFLV | 11 | Q5W188 | |
| ELALLCFTVLELFLP | 171 | Q96PG2 | |
| CFTVLELFLPVPTAV | 176 | Q96PG2 | |
| SVLVFLICSLPLSIY | 226 | Q8TDS7 | |
| RPETFLLAFVLLCTL | 6 | A6NC86 | |
| PVFFILACLFLIAVS | 436 | Q01650 | |
| VVAFFSLALLLAPLV | 406 | Q96FB5 | |
| PTVLLIDVSCFLFLI | 51 | O94886 | |
| VCPSEKRFLLLFTFL | 406 | Q9NVP1 | |
| TIAVVLAVFALCFLP | 246 | P41231 | |
| FLLAFLVPLAIIASS | 211 | Q9Y5Y4 | |
| FVLTCIIIVCSLLFP | 356 | Q9H490 | |
| ILSPFSFEVCLCLLV | 151 | P35410 | |
| CLFTLVASIIVPAAF | 6 | P55082 | |
| RKSFLLLTVFFTCAP | 101 | Q96MC6 | |
| VSAFLAPILALEFVL | 91 | Q8TDS5 | |
| CVFLFAFVVPILIIT | 216 | P41143 | |
| AIADFLFCVTLPFKI | 136 | O00254 | |
| FLLPVFSPLATLLAC | 226 | Q86SM5 | |
| SFVLFLFLGCLVVPL | 201 | Q9H1Y3 | |
| FLIIPCIGLSFLTVL | 256 | P30532 | |
| LTALLCLPAAFLDLF | 151 | Q8IZ08 | |
| LISIITFCLETLPEF | 261 | P22460 | |
| LTFVLALPSVALCTF | 31 | Q02221 | |
| TFSSPFCLLLIVALT | 271 | Q9P0K9 | |
| ISGCLFSILFPLFII | 261 | O14681 | |
| PIIICLSIIIAFLFI | 946 | Q9NZV1 | |
| ALFSQILLPAFFVCV | 1456 | Q9BZC7 | |
| SFLPFLLCAVLLSAV | 156 | O60427 | |
| LVISSLLDFLTFALC | 526 | O75165 | |
| LAISDFLVGAFCIPL | 76 | Q9Y5N1 | |
| VTHLFLPLVFLTGLC | 6 | O75578 | |
| VPLFSPCLLFILSTA | 261 | Q9C0D9 | |
| PLIFLGCCFFSTLVL | 996 | Q86Z14 | |
| LCTFVLPLLLFLAAI | 11 | O43174 | |
| SQIVFTFLLIPCCLT | 21 | P38567 | |
| LLLFVVLLAFCSATL | 191 | Q9NQ60 | |
| LAFIAGILFATLSCL | 96 | P51636 | |
| PFTITVVLLLSACFV | 26 | Q86VB7 | |
| PIFLCCVLAIVAFSL | 541 | Q9Y267 | |
| AFLILCLLSAAFAPI | 21 | O15245 | |
| LLFCLLISATVFRPG | 11 | Q13740 | |
| ITILFIELCTDIFPS | 816 | P20648 | |
| LPFLTSVTLCFGLIA | 541 | Q6UY18 | |
| FLEISFTSVCIPRFL | 66 | A6NL08 | |
| LSLVFSLVSVPLQCF | 536 | Q6J4K2 | |
| IISICVFVLTFSAPL | 66 | O15403 | |
| HTVLIATGCFIFLIP | 196 | P34982 | |
| AICIFLFSFIVPVLV | 216 | P41146 | |
| ISFRSFCIILPDVFL | 156 | Q8NGJ2 | |
| LLSTCFRSVFALPLL | 496 | Q6ZUA9 | |
| LFLSSIIPFDCLLTV | 166 | O43196 | |
| PVLFVSACLFILPVL | 391 | Q8WU17 | |
| SACLFILPVLLSYVL | 396 | Q8WU17 | |
| TLANLIPFTLSLICF | 181 | P59542 | |
| IPFTLSLICFLLLIC | 186 | P59542 | |
| VPFTLTLLCFLLLIC | 186 | P59538 | |
| TLANLIPFTLSLICF | 181 | P0DSN6 | |
| IPFTLSLICFLLLIC | 186 | P0DSN6 | |
| FVISSCAAFISVPLL | 256 | P59533 | |
| VPFTVTLISFLLLVC | 186 | P59539 | |
| VPFTLTLISFLLLIC | 186 | P59540 | |
| SILLCLLASGLVVFF | 91 | Q9BVX2 | |
| CLVSLLLTPSTLFLL | 961 | Q8N1F8 | |
| PCFIIVGFFIRTLLL | 301 | Q9GZN6 | |
| CLVLVFTVTLSVFPA | 296 | Q14542 | |
| TCPLTTVDALVLRFF | 86 | Q9NX61 | |
| CIFSIILSVFIPSLF | 16 | Q07326 | |
| TGVIFFLALLLCIAL | 76 | Q8WUX1 | |
| SDILVVLFCSPFTLT | 86 | Q15761 | |
| VLFCSPFTLTSVLLD | 91 | Q15761 | |
| PRLCGFLILLSFFIS | 156 | Q6IFN5 | |
| ITIPVQLLITFLFTC | 1436 | Q9NTG1 | |
| VPSNLTFTLFKCLLL | 776 | Q6ZW05 | |
| SIAIPLVIACLFFLV | 411 | Q01974 | |
| ALPIIIFFGCVVSIL | 261 | O43868 | |
| TSTCQRKPLLLVFIF | 571 | Q96BD0 | |
| VAGIPILFLSACFIT | 26 | Q9ULY5 | |
| TFPLVLILFSALFCH | 166 | P35523 | |
| LLPFFTLSICYLLII | 211 | Q9NS75 | |
| SVAIPLAIALLFFFI | 411 | Q01973 | |
| CAHFLLPAIFLISFV | 511 | Q92959 | |
| LPAIFLISFVSLIAC | 516 | Q92959 | |
| STKLFLNLATLLPFC | 181 | Q9NYW3 | |
| IADPICTFIFSILVL | 246 | Q8IWU4 | |
| VVVLACPLIFKLFSS | 81 | P32241 | |
| LLSLGCIFFPLLLFQ | 6 | P17643 | |
| GCLLVTLFFLTSLFP | 321 | Q8IUH4 | |
| SFLFAAPLILLVFAT | 481 | Q8N271 | |
| CTFLFSIAGPVLLIL | 121 | O60831 | |
| FLCLFARSLPFPTVL | 256 | Q8IV04 | |
| LVSPCFLLFVVVVSI | 526 | Q01959 | |
| VFLFTCGIPVFLLET | 76 | Q9NSD5 | |
| VLTFLCLSFNPLTSL | 486 | Q12772 | |
| FVIAFLSPLSLIFLA | 61 | Q8NEB5 | |
| CAFLSPLLFAAVIAL | 186 | Q8NEB5 | |
| LLFSCLCVLLAIFTA | 266 | Q9H5I5 | |
| IFIPTSFLLVCILHL | 791 | Q9H5I5 | |
| VFCICSVFLVIVPLF | 431 | Q92536 | |
| ADPLCSLFIAILIFL | 621 | Q8TAD4 | |
| ICLPVVFILSFVVSF | 166 | Q96HH4 | |
| AVVIASFLIICAAPF | 126 | Q6ZP80 | |
| IFLIALFISSPLICL | 766 | Q15849 | |
| LVIFFGLCLLSLLFI | 216 | P19438 | |
| VVGIFFLSAVPLVCL | 6 | O00124 | |
| VTCFIIGLLFPVFSV | 331 | Q9UBN4 | |
| TFCIVGFPDLAVILL | 171 | Q9UJK0 | |
| VDPICTFVFSILVLG | 201 | Q9BRI3 | |
| CFVVVLCAFLALPLS | 21 | A0A1B0GTI8 | |
| LPICTTVFIIFSRID | 36 | Q9BTX1 |